We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$156B
1-Year Est. Return
27.51%
This Fund
S&P 500
This Quarter
Est. Return
+5.54%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.77%
AUM
$49.6B
AUM Growth
+$5.62B
(+13%)
Cap. Flow
+$2.56B
Cap. Flow
% of AUM
5.15%
Top 10 Holdings %
Top 10 Hldgs %
6.81%
Holding
1,885
New
111
Increased
738
Reduced
863
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$178M |
| 2 |
Schwab Fundamental International Large Company Index ETF
FNDF
|
+$161M |
| 3 |
KLA
KLAC
|
+$151M |
| 4 |
Zions Bancorporation
ZION
|
+$148M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ingredion
INGR
|
+$85.6M |
| 2 |
Keysight
KEYS
|
+$83.3M |
| 3 |
ATI
ATI
|
+$81.4M |
| 4 |
Kennametal
KMT
|
+$66.6M |
| 5 |
Keurig Dr Pepper
KDP
|
+$65.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.46% |
| 2 | Industrials | 15.08% |
| 3 | Technology | 14.03% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Ameriprise Financial
AMP
$49.6B
| $22.7M | 0.05% |
156,209
+73,095
| +88% | +$10.6M |
|
552
Neurocrine Biosciences
NBIX
$16.4B
| $22.6M | 0.05% |
267,470
-268,630
| -50% | -$22.1M |
|
553
General Mills
GIS
$19.2B
| $22.5M | 0.05% |
429,342
+125,456
| +41% | +$6.48M |
|
554
Monster Beverage
MNST
$92.4B
| $22.4M | 0.05% |
702,700
-683,822
| -49% | -$20.6M |
|
555
Duke Energy
DUK
$96.2B
| $22.4M | 0.05% |
253,717
+14,570
| +6% | +$1.29M |
|
556
CytomX Therapeutics
CTMX
$729M
| $22.3M | 0.04% |
1,985,990
+330,460
| +20% | +$3.46M |
|
557
Kearny Financial
KRNY
$609M
| $22.3M | 0.04% |
1,674,209
+629,691
| +60% | +$8.47M |
|
558
Dominion Energy
D
$60B
| $22.2M | 0.04% |
287,741
+13,875
| +5% | +$1.06M |
|
559
Sunstone Hotel Investors
SHO
$2.18B
| $22.1M | 0.04% |
1,613,846
-58,954
| -4% | -$834K |
|
|
AEPPL
560
DELISTED
American Electric Power Company, Inc. Corporate Unit
AEPPL
| $22.1M | 0.04% |
412,623
+176,209
| +75% | +$9.23M |
|
561
Orthofix Medical
OFIX
$421M
| $22M | 0.04% |
416,844
+5,156
| +1% | +$274K |
|
|
SYNH
562
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $22M | 0.04% |
+430,269
| New | +$20M |
|
563
Chord Energy
CHRD
$7.32B
| $22M | 0.04% |
3,865,953
-36,769
| -0.9% | -$209K |
|
564
HUB Group
HUBG
$2.91B
| $21.9M | 0.04% |
1,045,244
+117,170
| +13% | +$2.46M |
|
565
Emerson Electric
EMR
$91B
| $21.9M | 0.04% |
327,593
+108,965
| +50% | +$7.3M |
|
566
Texas Instruments
TXN
$254B
| $21.8M | 0.04% |
189,953
+141,154
| +289% | +$15.8M |
|
567
Sempra
SRE
$55.3B
| $21.8M | 0.04% |
317,090
-120,016
| -27% | -$7.87M |
|
568
CryoPort
CYRX
$769M
| $21.7M | 0.04% |
1,186,220
+998,020
| +530% | +$15.8M |
|
|
CXO
569
DELISTED
CONCHO RESOURCES INC.
CXO
| $21.7M | 0.04% |
210,298
+75,100
| +56% | +$8.1M |
|
|
PPL
570
PPL Corp
PPL
$26.3B
| $21.7M | 0.04% |
698,540
+38,521
| +6% | +$1.19M |
|
571
JPMorgan Chase
JPM
$955B
| $21.6M | 0.04% |
193,635
+47,188
| +32% | +$5.2M |
|
572
Incyte
INCY
$24.3B
| $21.6M | 0.04% |
253,974
-95,733
| -27% | -$7.68M |
|
573
Gossamer Bio
GOSS
$86.9M
| $21.5M | 0.04% |
968,560
+107,960
| +13% | +$2.07M |
|
574
Piper Sandler
PIPR
$5.14B
| $21.3M | 0.04% |
1,148,256
-33,776
| -3% | -$638K |
|
575
Petrobras
PBR
$118B
| $21.3M | 0.04% |
1,369,093
-121,394
| -8% | -$1.85M |
|
Similar funds
Victory Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Victory Capital Management held 1,885 positions worth $49.6B, up 13% from $44B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
Victory Capital Management deployed $2.56B of net new capital in Q2 2019, opening 111 new positions and adding to 738 existing holdings. Its largest new stake was Goldman Sachs ActiveBeta US Large Cap Equity ETF: 3,081,520 shares worth $181M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Ingredion, an estimated $85.6M trimmed.
- Victory Capital Management's largest Q2 2019 buy was Goldman Sachs ActiveBeta US Large Cap Equity ETF: 3,081,520 shares worth $181M.
- Victory Capital Management added most to KLA in Q2 2019, an estimated $151M increase.
- Victory Capital Management's biggest Q2 2019 reduction was Ingredion, cutting an estimated $85.6M.
- Victory Capital Management fully exited Teladoc Health in Q2 2019, selling an estimated $50.5M.
- Victory Capital Management's ten largest holdings make up 6.8% of its $49.6B portfolio in Q2 2019.
- Victory Capital Management opened 111 new positions and closed 63 in Q2 2019.
- Victory Capital Management's portfolio value rose 13% quarter-over-quarter to $49.6B.
Based on Victory Capital Management's 13F filing for Q2 2019, filed 15 Aug 2019.